Results for "Understanding Pharmaceutical Distribution"
HDA Survey Results Indicate More Preparation Necessary for Connecting EPCIS-Enabled Systems Before DSCSA Deadline
Data released by the Healthcare Distribution Alliance (HDA) indicate more preparation is needed to ensure all healthcare supply chain partners are ready to meet the requirements of the Drug Supply Chain Security Act (DSCSA). HDA’s latest EPCIS Implementation Benchmarking Survey provides a final report on supply chain partners’ progress toward the November 27, 2023, deadline to connect data systems to exchange serialized transaction data for all pharmaceuticals.
Technological Innovations Reshaping the Healthcare Supply Chain
Almost every industry is exploring the groundbreaking potential of new technologies involving automation, artificial intelligence (AI) and machine learning (ML), and the healthcare supply chain is no exception. While rapid innovation always brings some degree of uncertainty, the healthcare distribution industry has already found exciting opportunities for automation, AI and ML to assist employees, while also creating efficiencies that ultimately benefit providers and their patients.
HDA Statement on “Most-Favored-Nation” Executive Order
HDA released a statement in response to President Donald J. Trump’s Executive Order establishing a “Most-Favored-Nation” (MFN) pricing policy for pharmaceuticals.